Literature DB >> 27767292

Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.

Brent M Egan1,2, Bo Kai3, C Shaun Wagner2, Douglas O Fleming2, Joseph H Henderson1, Archie H Chandler1, Angelo Sinopoli1,2.   

Abstract

Apparent treatment-resistant hypertension (aTRH) may confound the reported relationship between low blood pressure (BP) and increased cardiovascular disease (CVD) in treated hypertensive patients. Incident CVD was assessed in treated hypertensive patients with and without aTRH (BP ≥140 and/or ≥90 mm Hg on ≥3 medications or <140/<90 mm Hg on ≥4 BP medications) at three BP levels: 1: <120 and/or <70 mm Hg and <140/<90 mm Hg; 2: 120-139/70-89 mm Hg; and 3: ≥140 and/or ≥90 mm Hg. Electronic health data were matched to emergency and hospital claims for incident CVD in 118 356 treated hypertensive patients. In adults with and without aTRH, respectively, CVD was greater in level 1 versus level 2 (multivariable hazard ratio, 1.88 [95% confidence interval [CI], 1.70-2.07]; 1.71 [95% CI, 1.59-1.84]), intermediate in level 1 versus level 3 (hazard ratio, 1.32 [95% CI, 1.21-1.44]; 0.99, [95% CI, 0.92-1.07]), and lowest in level 2 versus level 3 (hazard ratio, 0.70 [95% CI, 0.65-0.76]; 0.58, [95% CI, 0.54-0.62]). Low treated BP was associated with more CVD than less stringent BP control irrespective of aTRH. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27767292      PMCID: PMC5837034          DOI: 10.1111/jch.12904

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  33 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

3.  Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Marta Garofoli; Gianpaolo Reboldi
Journal:  Hypertension       Date:  2014-01       Impact factor: 10.190

4.  Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM.

Authors:  Gerd Assmann; Paul Cullen; Thomas Evers; Dieter Petzinna; Helmut Schulte
Journal:  Eur Heart J       Date:  2005-09-01       Impact factor: 29.983

5.  Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon; Walter A Brzezinski; Keith C Ferdinand
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

6.  Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.

Authors:  Jeffrey R Curtis; Joseph C Larson; Elizabeth Delzell; Maurice Alan Brookhart; Suzanne M Cadarette; Rowan Chlebowski; Suzanne Judd; Monika Safford; Daniel H Solomon; Andrea Z Lacroix
Journal:  Med Care       Date:  2011-05       Impact factor: 2.983

7.  High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension.

Authors:  Nieves Martell; Matilde Rodriguez-Cerrillo; D E Grobbee; M Dolores López-Eady; Carmen Fernández-Pinilla; Mario Avila; Arturo Fernández-Cruz; Manuel Luque
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

Review 8.  The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?

Authors:  Franz H Messerli; Gurusher S Panjrath
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

9.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

10.  Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure.

Authors:  Kazuomi Kario; Kazuyuki Shimada
Journal:  Clin Exp Hypertens       Date:  2004-02       Impact factor: 1.749

View more
  4 in total

1.  Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.

Authors:  Brent M Egan; Bo Kai; C Shaun Wagner; Douglas O Fleming; Joseph H Henderson; Archie H Chandler; Angelo Sinopoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-21       Impact factor: 3.738

2.  The J-curve between Diastolic Blood Pressure and Risk of All-cause and Cardiovascular Death.

Authors:  Heejin Kimm; Yejin Mok; Sun Ju Lee; Sunmi Lee; Joung Hwan Back; Sun Ha Jee
Journal:  Korean Circ J       Date:  2018-01       Impact factor: 3.243

3.  Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.

Authors:  Francesca Viazzi; Pamela Piscitelli; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Pietro Guida; Giuseppina Russo; Salvatore De Cosmo; Roberto Pontremoli
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

4.  Personalized Blood Pressure Targets in Shock: What If Your Normal Blood Pressure Is "Low"?

Authors:  James A Russell
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.